MedPath

ROUSSELOT BVBA

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:4

Trial Phases

1 Phases

Not Applicable:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (100.0%)

Effect of Chronic Exposure to Nextida GC-B on Glycemic Control in Adults With Normoglycemia and Prediabetes

Not Applicable
Not yet recruiting
Conditions
Normoglycemia
Prediabetes
Glycemic Control
First Posted Date
2025-08-29
Last Posted Date
2025-08-29
Lead Sponsor
Rousselot BVBA
Target Recruit Count
60
Registration Number
NCT07149064
Locations
🇨🇦

KGK Science Inc., London, Ontario, Canada

To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Symptoms.

Not Applicable
Recruiting
Conditions
Gastrointestinal Disorders
First Posted Date
2025-04-22
Last Posted Date
2025-07-23
Lead Sponsor
Rousselot BVBA
Target Recruit Count
116
Registration Number
NCT06937801
Locations
🇨🇦

Nutrasource Site (Apex Trials), Guelph, Ontario, Canada

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects

Not Applicable
Recruiting
Conditions
Prediabetes
Normoglycemic
First Posted Date
2025-01-23
Last Posted Date
2025-02-14
Lead Sponsor
Rousselot BVBA
Target Recruit Count
30
Registration Number
NCT06789263
Locations
🇩🇪

BioTeSys GmbH, Esslingen, Germany

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

Not Applicable
Completed
Conditions
Tolerance
First Posted Date
2024-01-30
Last Posted Date
2025-05-09
Lead Sponsor
Rousselot BVBA
Target Recruit Count
60
Registration Number
NCT06232460
Locations
🇺🇸

Atlantia Clinical Trials, Chicago, Illinois, United States

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects

Not Applicable
Completed
Conditions
Healthy
Prediabetic State
First Posted Date
2023-06-05
Last Posted Date
2024-12-17
Lead Sponsor
Rousselot BVBA
Target Recruit Count
15
Registration Number
NCT05887791
Locations
🇩🇪

BioTeSys GmbH, Esslingen, Germany

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.